IQVIA Holdings Inc. (IQV) remains a key player in the bio-tech industry. The company has seen numerous transactions, with Quadrature Capital Ltd, Covestor Ltd, and UniSuper Management, among others, making substantial acquisitions of IQVIA shares. Conversely, Osaic Holdings Inc., Toronto Dominion Bank, FDx Advisors Inc., and Trillium Asset Management made significant sales. FY2024 earning forecasts suggest earning per share (EPS) of $10.24, exceeding expectations. Analysts have subsequently boosted estimates for IQVIA. Notably, the company's earnings and revenue surpassed Q1 and Q2 estimates, causing a surge in stock value. Such performance has led to the revised price targets, raised to $280.00 by Morgan Stanley and to $300.00 by Truist Financial. Despite fluctuating performances on the trading floor, IQVIA still shows signs of promise. A note of caution comes from Jefferies shifting IQVIA stock to 'Hold' due to booking and competitive pressures.
Iqvia Holdings IQV News Analytics from Wed, 14 Feb 2024 08:00:00 GMT to Sun, 28 Jul 2024 15:49:37 GMT -
Rating 8
- Innovation 4
- Information 9
- Rumor -2
